Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Boostrix Polio versus Repevax booster co-administered with Priorix in preschool children
2009-012202-39Phase 3Completed
- Sponsor
- GSK
- Start
- Jul 2010
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial in diphtheria, Tetanus, pertussis and 4 more comparing Boostrix Polio + Priorix with Repevax + Priorix (2 arms). Primary endpoints: Primary immunogenicity endpoint and Non-inferiority objective. Started Jul 2010; status: completed.
02
Drugs
Boostrix PolioAdacel Poliomeasles, mumps and rubella vaccine (live)
03
Conditions
diphtheriaTetanuspertussispoliomyelitismeasles
Beyond the preview
Go deeper on 2009-012202-39.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2009-012202-39.